# OnCo record pleural-mesothelioma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/pleural-mesothelioma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "pleural-mesothelioma" ;
  schema:name "Pleural mesothelioma"@en ;
  schema:alternateName "Malignant pleural mesothelioma"@en, "MPM"@en ;
  schema:description "Pleural mesothelioma grows in the lining of the lung after asbestos exposure and causes breathlessness and chest pain from fluid and thickening. It is rarely curable; the first-line choice is nivolumab with ipilimumab or pembrolizumab with chemotherapy, and surgery to remove the lining is no longer recommended outside trials."@en ;
  schema:url <https://onco.cc/cancers/pleural-mesothelioma/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Mesothelioma> ;
  schema:citation <https://en.wikipedia.org/wiki/Mesothelioma>, <https://www.mesothelioma.uk.com/> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/peritoneal-mesothelioma/> ;
  onco:terms <https://onco.cc/terms/bap1-loss/>, <https://onco.cc/terms/cdkn2a-homozygous-deletion/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-checkmate-743-lancet-2021/>, <https://onco.cc/key-papers/paper-vogelzang-pemetrexed-mesothelioma-jco-2003/>, <https://onco.cc/key-papers/paper-mars-2-lancet-respir-med-2024/>, <https://onco.cc/key-papers/paper-keynote-483-lancet-2023/> ;
  onco:pipeline <https://onco.cc/ideas/idea-adc-for-mesothelioma/> ;
  onco:standardOfCare <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/trials/checkmate-743/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/pemetrexed/>, <https://onco.cc/trials/keynote-483/>, <https://onco.cc/trials/mars-2/>, <https://onco.cc/drugs/nivolumab/> .